Proteomics analysis of malignant and benign prostate tissue by 2D DIGE/MS reveals new insights into proteins involved in prostate cancer.
about
The Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate CancerProteomics and peptidomics: moving toward precision medicine in urological malignanciesThe Genetic Architecture of Murine Glutathione TransferasesProteomic Upregulation of Fatty Acid Synthase and Fatty Acid Binding Protein 5 and Identification of Cancer- and Race-Specific Pathway Associations in Human Prostate Cancer Tissues.Construction and analysis of protein-protein interaction networks based on proteomics data of prostate cancerProstate cancer proteomics: Current trends and future perspectives for biomarker discovery.Palmitoylation: a protein S-acylation with implications for breast cancer.Differentially Expressed Genes and Signature Pathways of Human Prostate Cancer.Identifying DCN and HSPD1 as Potential Biomarkers in Colon Cancer Using 2D-LC-MS/MS Combined with iTRAQ Technology.Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer.iTRAQ-Based Quantitative Proteomic Analyses of High Grade Esophageal Squamous Intraepithelial Neoplasia.The role of microfibrillar-associated protein 4 (MFAP4) in the formation and function of splenic compartments during embryonic and adult life.Pathway-based expression profiling of benign prostatic hyperplasia and prostate cancer delineates an immunophilin molecule associated with cancer progression.Proteomic Characterization of Prostate Cancer to Distinguish Nonmetastasizing and Metastasizing Primary Tumors and Lymph Node Metastases.Prostate cancer proteomics: clinically useful protein biomarkers and future perspectives.DIGE Analysis Software and Protein Identification Approaches.Effect of purified fractions from cell culture supernate of high-density pre-B acute lymphoblastic leukemia cells (ALL3) on the growth of ALL3 cells at low density.2D-DIGE and Fluorescence Image Analysis.Infiltrating Myeloid Cells Exert Protumorigenic Actions via Neutrophil Elastase.
P2860
Q26738703-9E69A124-6075-4FF4-8AC2-73C41CA86B8BQ26749401-1F97901F-0FD8-4812-8D44-5BFFD3F17373Q28553004-83C4C678-FE57-4A1A-96A5-275E839AF688Q30357469-F8583AE6-2D5A-498E-BA52-48C9CD99207DQ31086270-D066CE6A-8C6C-40BE-B652-19B2F5A26A79Q33567004-E5C43A16-EB3A-4D5C-85EE-F0AC7EEA432AQ33915087-899342F7-A19E-427A-946E-69D15D09B751Q35873154-6E01E0FB-EF7A-4C71-8900-A76E0AE50502Q36297724-757ACFE2-56B8-4FE6-82F7-EFB3E1F35A46Q37648510-FA4F0DCD-9BC9-46EF-8234-D9A639779FFFQ38429715-CF5B42D4-5FD9-413C-938E-E6765D8F2089Q39980617-0D87BDC1-64ED-422C-A924-C4BEAAFD59ABQ41548014-1A72725D-9702-45D2-A3AB-9E9B8788407BQ47257677-A15CE67B-B802-43B7-A2FA-1F0D67FA4D16Q47282493-0B700CD8-3023-4041-8D84-73F62B9AC03CQ47668016-820C6D4B-AC62-411D-AABF-ACDD34E0C921Q49798718-2DACCEFB-F3AE-4307-A5F2-37902C2F10B0Q50091994-DE2CC605-FF3E-40B9-88D8-6A2B34C71293Q52770285-5D3B04A4-AF62-4AD3-AE5D-871412EBF439
P2860
Proteomics analysis of malignant and benign prostate tissue by 2D DIGE/MS reveals new insights into proteins involved in prostate cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Proteomics analysis of maligna ...... s involved in prostate cancer.
@en
Proteomics analysis of maligna ...... s involved in prostate cancer.
@nl
type
label
Proteomics analysis of maligna ...... s involved in prostate cancer.
@en
Proteomics analysis of maligna ...... s involved in prostate cancer.
@nl
prefLabel
Proteomics analysis of maligna ...... s involved in prostate cancer.
@en
Proteomics analysis of maligna ...... s involved in prostate cancer.
@nl
P2093
P2860
P356
P1433
P1476
Proteomics analysis of maligna ...... ns involved in prostate cancer
@en
P2093
Gordana Petrusevska
Ivana Maleva Kostovska
Katerina Kubelka-Sabit
Katerina Markoska
Momir Polenakovic
Oliver Stankov
Sanja Kiprijanovska
Selim Komina
Sotir Stavridis
Vanja Filipovski
P2860
P304
P356
10.1002/PROS.23034
P577
2015-06-12T00:00:00Z